Efficacy of a device to narrow the coronary sinus in refractory angina

Area of Science:

• Cardiology
• Interventional Cardiology
• Medical Devices

Background:

• Refractory angina significantly impacts patients with coronary artery disease (CAD) ineligible for revascularization.
• Standard medical therapy often fails to alleviate symptoms in these patients.
• The coronary sinus reducing device offers a novel approach to redistribute blood flow to ischemic myocardium.

Purpose of the Study:

• To evaluate the efficacy of a coronary sinus reducing device in patients with refractory angina.
• To assess improvements in Canadian Cardiovascular Society (CCS) angina class and quality of life.

Main Methods:

• A randomized controlled trial involving 104 patients with CCS class III/IV angina and myocardial ischemia.
• Patients were randomized to either device implantation or a sham procedure.
• The primary endpoint was the proportion of patients with at least a two-class improvement in CCS angina at 6 months.

Main Results:

• 35% of patients receiving the device showed a ≥2 CCS class improvement versus 15% in the control group (P=0.02).
• Significant improvements were observed in at least one CCS class (71% vs. 42%, P=0.003) and quality of life (Seattle Angina Questionnaire, P=0.03).
• No significant differences in exercise time or wall-motion index; adverse events were comparable between groups.

Conclusions:

• The coronary sinus reducing device demonstrated significant symptom and quality of life improvements in patients with refractory angina.
• This small trial suggests a potential new therapeutic option for this patient population.
• Further research is warranted to confirm these findings in larger studies.